United States · FDA National Drug Code directory
Ezetimibe
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-052_60081062-9f4b-4cf5-9c24-02b5a0b7f792
- Product NDC
- 59651-052
- Form
- TABLET
- Composition / generic term
- Ezetimibe
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170825
- Source listing expiry
- 20261231
Source-listed ingredients
- EZETIMIBE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (59651-052-05) · 59651-052-05
- 30 TABLET in 1 BOTTLE (59651-052-30) · 59651-052-30
- 90 TABLET in 1 BOTTLE (59651-052-90) · 59651-052-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →